Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.
about
TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications?Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes.Association of tumor necrosis factor-α (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.
P2860
Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Etanercept reduces matrix meta ...... and TNF-alpha-308GG genotype.
@en
Etanercept reduces matrix meta ...... and TNF-alpha-308GG genotype.
@nl
type
label
Etanercept reduces matrix meta ...... and TNF-alpha-308GG genotype.
@en
Etanercept reduces matrix meta ...... and TNF-alpha-308GG genotype.
@nl
prefLabel
Etanercept reduces matrix meta ...... and TNF-alpha-308GG genotype.
@en
Etanercept reduces matrix meta ...... and TNF-alpha-308GG genotype.
@nl
P2093
P50
P1476
Etanercept reduces matrix meta ...... s and TNF-alpha-308GG genotype
@en
P2093
Andrej Veljkovic
Gordana Susic
Ivana Stojanovic
Milena Marinkovic
Tatjana Jevtovic-Stoimenov
P2888
P304
P356
10.1007/S13105-010-0022-X
P577
2010-06-01T00:00:00Z